AnalystBook Research · Company Intelligence

CARDINAL HEALTH INC

CAHNYSE

Built from CARDINAL HEALTH INC's own SEC filings · updates as new filings land · sources cited throughout

or browse all covered companies

Revenue up 14% to $254B on a one percent operating margin, with CVS at 28% of it

The read at a glance✓ Audited against SEC data
  • Growth — Revenue up 14% to $254.25B; gross margin up 20% to $9.77BOK
  • Profitability — Operating earnings $2.61B, about 1% of revenueWatch
  • Balance sheet — Altman score -0.22, below the model's lowest band, against $4.53B of free cash flowWatch
  • Accounting quality — Earnings-quality score 100 and no earnings-manipulation flagOK
  • Capital allocation — $1.36B buybacks and $0.49B dividends against $4.53B free cash flowOK
  • Customer concentration — CVS Health alone is 28% of revenueWatch

What happened

Cardinal Health grew revenue 14% to $254.25 billion and gross margin 20% to $9.77 billion. Total segment profit rose 29% to $3.75 billion, but consolidated operating earnings rose 15% to $2.61 billion because corporate costs widened from $634 million to $1,135 million.

Where the revenue comes from

Fiscal 2026, as CARDINAL HEALTH INC reports it. History and quarterly detail are in the app.

  • Pharmaceutical and Specialty Solutions$234.8B
  • GMPD$12.7B
  • Other Operating$6.8B

Leadership changes

From CARDINAL HEALTH INC's own filings, the day they're filed.

  • Anita Zielinski · Chief Accounting Officer · appointmenteff. 2026-11-05
  • Mary Scherer · Chief Accounting Officer · appointmenteff. 2026-11-05
  • Sudhakar Ramakrishna · Directors · departureeff. 2025-03-07

Latest filings

  • 8-K · Company announcement2026-10-01
  • DEF 14A · Annual proxy (pay & governance)2026-09-21
  • 10-K · Annual report2026-08-11
  • 8-K · Company announcement2026-08-11
  • 8-K · Company announcement2026-08-11
In the full recordFree for 14 days
  • The business🔒
  • What changed🔒
  • Insider signal🔒
  • Growth quality🔒
  • Margins & accounting🔒
  • Capital allocation🔒
  • Real risks🔒
  • The long arc🔒
  • Company history🔒
  • Why it matters🔒
  • The filings, readable — with what changed vs the prior year highlighted🔒
  • Full financial statements, industry-aware, sources cited throughout🔒
  • Forensic score history & components — the trend, not one year🔒
  • Ownership: insider buys/sells, clusters, activist stakes🔒
  • Ana — ask about CARDINAL HEALTH INC, every answer cited to the official filings🔒

Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.

14-day free trial, no credit card. For research purposes only; not investment advice.